All articles tagged with #heparin
A meta-trial across six countries found that inhaled heparin significantly reduces the risk of intubation and death in hospitalized COVID-19 patients, likely due to its antiviral, anti-inflammatory, and anti-coagulant properties, suggesting potential broader applications for respiratory diseases.
A new international study shows that inhaled heparin, a common and affordable blood thinner, significantly improves outcomes for seriously ill COVID-19 patients by reducing ventilation needs and mortality, with potential applications for other respiratory infections; further development and trials are underway.
Australian professor, Professor Don Campbell, claims to have avoided contracting Covid-19 and other respiratory infections by using a heparin-based nasal spray twice a day since May 2020. Heparin, an anticoagulant, is believed to bind to the Covid protein spike and prevent its proliferation. Prof Campbell and a team of researchers are now conducting a study to test the effectiveness of heparin on Covid infections and are seeking volunteers. The study aims to determine if heparin can treat early Covid-19 infections and prevent transmission among close contacts.